Status:
WITHDRAWN
Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Conditions:
Kidney Transplantation
Plasmapheresis
Eligibility:
All Genders
18-75 years
Brief Summary
Based on the limited amount of experience with plasmapheresis and CytoGam concomitant use, the researchers seek to evaluate the pharmacokinetics (drug absorption, distribution, and elimination) of thi...
Detailed Description
Kidney transplantation has emerged as a desired treatment of choice for patients with end stage renal disease. Although transplantation has become increasingly successful, there continues to be risks ...
Eligibility Criteria
Inclusion
- Patient is a male or female.
- Age of 18-75.
- Patient must have the ability to provide informed consent.
- Positive cross-match with intended donor and/or ABO incompatible with intended donor.
Exclusion
- Patients under the age of 18 or over the age of 75.
- Women that are currently pregnant.
- Patient has a history of any illness that, in the opinion of the investigator(s), might confound the results of the study or pose additional risk to the patient.
Key Trial Info
Start Date :
February 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00203281
Start Date
February 1 2003
End Date
September 1 2009
Last Update
October 21 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University
New York, New York, United States, 10032
2
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107